PDT Treatment Centers

Select to filter results by state

Alabama

Birmingham

California

Beverly Hills

Cedars Sinai Medical Center

150 N. Robertson Bldv
Suite 150
Beverly Hills, CA 91211

NSCLC (Lung Cancer)
Clark Fuller, MD

Los Angeles

Cedars Sinai Medical Center

8631 W. 3rd Street, Suite 240E
Los Angeles, CA     90048
310-423-2640

NSCLC (LUNG CANCER)
Harmik Soukiasian, MD

 

Florida

Gainesville

Shands at the University of Florida

1600 SW Archer Rd
Gainesville, FL     32610
352-265-0111

NSCLC (LUNG CANCER)
Hiren Mehta MD
hiren.mehta@medicine.ufl.edu

Michael A Jantz MD,
352-273-8589


ESOPHAGEAL

Vincent Daniel MD

Jacksonville

Mayo Clinic

4500 San Pablo Rd.
Jacksonville, FL     32224
904-953-2221
pdt@mayo.edu

ESOPHAGEAL & BARRETT’S
Herbert C. Wolfsen, MD

Tampa

Moffitt Cancer Center

12902 USF Magnolia Dr Ste FOB1
Tampa, FL     33612
(813) 745-6895

NSCLC (LUNG CANCER)
Frank Kaszuba MD
813.745.8390

Eric M. Toloza MD, PhD
813.745.8390

Georgia

Atlanta

Piedmont Hospital

1968 Peachtree Rd NW
Atlanta, GA     30309
404-605-5000

NSCLC (LUNG CANCER) & ESOPHAGEAL 
Saeid Khansarinia, MD
saeid.khansarinia@piedmont.org

Newnan

Kentucky

Louisville

University of Louisville

401E Chestnut Street
Suite 310
Louisville, KY 40202
502-588-4600

NSCLC (LUNG CANCER)
Tanya Weiss, DO

Indiana

Seymour

Schneck Medical Center

Pulmonary Medicine
411 W. Tipton Street
Seymour, IN    47274
812-376-5757

NSCLC (LUNG CANCER)
David Wilson, MD

Illinois

Chicago

University of Chicago

5700 S. Maryland Ave
Chicago, IL     60637
773-702-0737

NSCLC (LUNG CANCER)
Septimiu Murgu, MD

Peoria

OSF St. Francis Medical Center

Peoria Surgical Group
1001 Main Street, Suite 300
Peoria, IL     61606
309-495-0200

NSCLC (LUNG CANCER)
Richard C. Anderson, MD

Louisiana

Kenner

Ochsner Medical Center

200 W Esplanade Ave  Suite 313
Kenner LA     70065
504-842-7690

ESOPHAGEAL 
Virenda Joshi MD
tash.tripp@oschner.org

Michigan

Detroit

Henry Ford Health System

2799 W Grand Blvd.
Detroit, MI     48202
800-436-7936

NSCLC (LUNG CANCER)
Michael Simoff MD

Nebraska

Omaha

The University of Nebraska Medical Center

982315 Nebraska Medical Center
Omaha, NE     68198
402-559-4389

NSCLC (LUNG CANCER)
Rudy P. Lackner, MD, FACS FCCP

North Carolina

Durham

Duke University Hospital

ERWIN RD
DURHAM NC 27704
919-684-8111

NSCLC (LUNG CANCER)

Momen Wahidi, MD
momen.wahidi@duke.edu
919-668-0340

NSCLC (LUNG CANCER) & ESOPHAGEAL 
Tom D’Amico, MD
angela.wiley@duke.edu
919-681-0491

Pennsylvania

Pittsburgh

Allegheny Health Network

320 East North Ave
Suite 363
Pittsburgh, PA 15212
412-359-6137

NSCLC (Lung Cancer) & ESOPHAGEAL
Blair Jobe, MD
Matthew VanDeusen, MD

Wynnewood

Main Line Health

Lankenau Medical Science Building
100 East Lancaster Avenue,
Suite 275
Wynnewood, PA      19096
610-527-1600

NSCLC (LUNG CANCER) & ESOPHAGEAL 
Patrick Ross, MD

Texas

Houston

MD Anderson Cancer Center

1515 Holcombe Blvd
Houston TX     77030
713-792-4015

NSCLC (LUNG CANCER)
George Eapen, MD

Mt. Pleasant

Titus Regional Medical Center

301 W 18th St Suite 101
Mt. Pleasant, TX     75455
903-572-9050

NSCLC (LUNG CANCER)
Gordon Downie, MD PhD

Wisconsin

Madison

University of Wisconsin Medical Center

600 Highland Avenue
Madison, WI 53792
608-263-7203

NSCLC (LUNG CANCER)
J.Scott Ferguson, MD

IMPORTANT SAFETY INFORMATION AND INDICATION

Do not take PHOTOFRIN (porfimer sodium) for injection:

  • If you have a rare disorder with a blood component called porphyria
  • If you have an abnormal connection (fistula) between the esophagus and airways leading to the lungs
  • If you have a tumor extending into a major blood vessel
  • If you have life-threatening breathing failure due to an obstructing airway tumor that requires emergency treatment
  • If you have enlarged veins in the stomach or esophagus or large ulcers in the esophagus

What should I tell my healthcare provider before taking PHOTOFRIN?

Before taking PHOTOFRIN, tell your healthcare provider about all your medical conditions, including if you are:
  • Taking other medicines that are activated by light
  • Taking other medicines during your photodynamic treatment with PHOTOFRIN
  • If you are pregnant or are a nursing mother

What is the most important information I should know about PHOTOFRIN?

  • Sensitivity or allergic reaction to light should be expected; eye sensitivity is possible. This reaction is called phototoxicity, which has a sunburn-like effect and may be severe. All patients receiving PHOTOFRIN will be sensitive to light and must take precautions to avoid exposure of eyes and skin to direct sunlight or bright indoor light for at least 30 days, but it may be required for more than 90 days. The phototoxicity with PHOTOFRIN is unique since it is activated, not only by UV light, but also by light visible to your eyes that is usually safe for humans. Phototoxicity reactions with PHOTOFRIN can occur following the first exposure to direct sunlight or intense indoor light from within a few minutes to up to several hours after exposure; resulting skin damage can persist. After PHOTOFRIN administration, when outside wear protective clothing and dark sunglasses which let less than 4% white light through.
  • An abnormal connection (fistula) can occur if an esophageal tumor is eroding into the main airway leading to the lungs or into one of its branches
  • Holes can develop through the wall of the organs in your digestive system where photodynamic therapy was applied (esophagus, stomach, small intestine, large bowel, rectum, gallbladder)
  • Bleeding can occur if you have enlarged veins in your esophagus
  • Some patients with treated lung cancer lesions are at high risk for coughing up life-threatening amounts of blood
  • If you are being treated for pre-cancerous cells (high-grade dysplasia) in Barrett’s esophagus, biopsy of your esophagus will be performed every 3 months and checked by your doctor until 4 consecutive biopsies are negative for high-grade dysplasia
  • If you require radiotherapy after treatment with PHOTOFRIN, the radiotherapy should not be started until 2-4 weeks after your PHOTOFRIN treatment
  • You may experience chest pain or breathing difficulty. Notify your doctor if you experience chest pain or any other side effects after treatment with PHOTOFRIN. Your doctor may prescribe medication to help reduce the pain.
  • Photodynamic therapy for advanced lung cancer may block the main lung airway, leading to life-threatening difficulty breathing
  • Narrowing of the esophagus occurs frequently after treatment of pre-cancerous cells (high-grade dysplasia) in Barrett’s esophagus
  • If you have liver or kidney problems you may be need to take extra precautions regarding sensitivity to light and for a longer time period
  • Blockage of blood vessels from pieces of a blood clot can happen after treatment with PHOTOFRIN

What are the possible side effects of PHOTOFRIN?

Sensitivity to light will occur in all patients. Allergic reaction to light may occur in all of the following indications:
  • For esophageal cancer (treatment of the esophagus): anemia, accumulation of fluid in the lungs, fever, constipation, nausea, chest pain, general pain, stomach pain, difficulty breathing, pneumonia (infection of the lung), vomiting, difficulty sleeping, back pain, inflammation of the throat
  • For obstructing endobronchial cancer (when cancer blocks the lungs airways): difficulty breathing, coughing with or without small amounts of blood, fever, coughing, pneumonia (infection of the lungs)
  • For superficial endobronchial tumors (when cancer slightly invades surrounding tissues): fluid leaking out of blood vessels into nearby tissue,  blockage of lung airways, swelling of tissue due to large fluid volume, narrowing of the main airway leading to lungs
  • High-grade dysplasia (pre-cancerous cells) in Barrett’s Esophagus (treatment of the esophagus): narrowing of the esophagus, vomiting, chest pain, nausea, fever, constipation, difficulty or pain when swallowing, abdominal pain, accumulation of fluid in the lungs, dehydration
These are not all the possible side effects of PHOTOFRIN. For more information call your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 or call Concordia Laboratories Inc. at 1-866-248-2039.

Indication

PHOTOFRIN is used for:
  • Relieving symptoms of esophageal cancer when the cancer blocks the esophagus or when the cancer cannot be treated by laser alone.
  • Treating non-small-cell lung cancer that slightly invades surrounding tissues when the other usual treatments are not appropriate
  • Relieving symptoms and reducing obstruction of non-small-cell lung cancer in patients in whom the cancer blocks the lung airways
  • Removal of abnormal, pre-cancerous cells (high-grade dysplasia) in Barrett’s esophagus when there is no removal of the esophagus by surgery
Please see Full Prescribing Information.

-------

PHOTOFRIN®, Pinnacle Biologics™ and the logo of Pinnacle Biologics™ are trademarks of Pinnacle Biologics, Inc. See more.

The PHOTOFRIN® trademark is owned by Concordia Laboratories Inc.

PHOTOFRIN® is manufactured for Concordia Laboratories Inc. and distributed in the United States by Pinnacle Biologics Inc. See more.

- See more at: http://pinnaclebiologics.com/